TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Thg 04 21, 2026
2 min read
62

A U.S. federal judge has delayed Purdue Pharma's criminal sentencing by one week to April 28, citing the need for public participation. The decision came after victims of the opioid crisis appeared in court. The hearing was set to finalize a 2020 guilty plea, which includes a $3.5 billion criminal fine and $2 billion in criminal forfeiture for the company's role in the opioid epidemic.
This sentencing is a critical step toward completing Purdue's bankruptcy settlement. The plan involves dissolving the company and using its assets to establish a $7.4 billion fund for those harmed by the crisis. The agreement, reached with the Department of Justice, directs most of the company's remaining assets to creditors, primarily state and local governments, rather than paying the full federal fines.
Under the 2020 plea deal, Purdue admitted to charges of defrauding the government and paying illegal kickbacks to doctors. As part of the bankruptcy proceedings, the federal government will receive only $225 million of the imposed penalties. Purdue's owners, members of the Sackler family, are contributing a minimum of $6.5 billion to fund the overall settlement, which will support opioid abatement and treatment programs.
The court will reconvene to allow victims to voice their experiences in person before finalizing the sentence. This delay underscores the human element in a landmark corporate criminal case. The outcome will pave the way for distributing settlement funds intended to address the nationwide public health crisis.
Q: Why was Purdue Pharma's sentencing delayed?
A: The sentencing was postponed to allow victims and members of the public who appeared at the courthouse to be heard in person.
Q: What is the total criminal penalty Purdue Pharma faces?
A: The company faces a $3.5 billion criminal fine and $2 billion in criminal forfeiture, though most of this amount will be waived to pay other creditors under the bankruptcy plan.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

03 Thg 05 2026
Aluminium Market Faces Disruption Amid Conflict

03 Thg 05 2026
Foxconn Enters Space Sector with SpaceX Satellite Launch

03 Thg 05 2026
Fed's Barr Warns of Private Credit Contagion Risk

03 Thg 05 2026
Kuwait to Boost Oil Production to 2.628M BPD in June

03 Thg 05 2026
AI Cuts Jobs But Boosts Productivity, Survey Shows

03 Thg 05 2026
Trump Halts US Wind Farms Over Security Concerns

03 Thg 05 2026
S&P 500 Rally Exceeds Norms; Internals Show Weakness

03 Thg 05 2026
Saudi Stocks Edge Up; Tadawul All Share Gains 0.05%